SCHEMBL14069752

SCHEMBL14069752

Cc1cn(-c2cc(C(=O)Nc3ccc(C)c(Nc4nn(C)c5c4cnc4[nH]ccc45)c3)cc(C(F)(F)F)c2)cn1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.59
CSF1R P07333 2/20 0.58
KDM4E B2RXH2 1/20 0.56
POLB P06746 1/20 0.56
RECQL P46063 1/20 0.56
MAPK14 Q16539 2/20 0.54
MAP3K20 Q9NYL2 2/20 0.54
MAP4K2 Q12851 2/20 0.53
MAP3K7 O43318 1/20 0.53
ABL1 P00519 7/20 0.51
BRAF P15056 5/20 0.51
BCR P11274 3/20 0.51
SRC P12931 3/20 0.51
LCK P06239 2/20 0.51
FYN P06241 2/20 0.51
YES1 P07947 2/20 0.51
LYN P07948 2/20 0.51
HCK P08631 2/20 0.51
PDGFRA P16234 2/20 0.51
FRK P42685 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14069756 0.87 BRAF (0.60) CSF1RMAPK14MAP4K2MAP3K7ABL1
SCHEMBL14069754 0.85 PIKFYVE (0.60) CSF1RPOLBBRAFKDRKIT
SCHEMBL14069583 0.84 CSF1R (0.58) MAPTCSF1RKDM4EPOLBRECQL
SCHEMBL4788935 0.82 CSF1R (0.63) MAPTCSF1RKDM4EPOLBRECQL
SCHEMBL4787141 0.81 CSF1R (0.67) MAPTCSF1RKDM4EPOLBRECQL
SCHEMBL4788638 0.81 CSF1R (0.69) MAPTCSF1RKDM4EPOLBRECQL
SCHEMBL13708168 0.80 CSF1R (0.61) MAPTCSF1RKDM4EPOLBRECQL
SCHEMBL15381989 0.79 CSF1R (0.71) MAPTCSF1RKDM4EPOLBRECQL
SCHEMBL4587496 0.79 CSF1R (0.56) MAPTCSF1RKDM4EPOLBRECQL
SCHEMBL3388334 0.79 CSF1R (0.60) MAPTCSF1RKDM4EPOLBRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008112695-A2 PYRAZOLO [3,4-D] PYRIMIDINES AND 1, 2, 5, 6-TETRAAZA- AS- INDACENES AS PROTEIN KINASE INHIBITORS FOR CANCER TREATMENT IRM LLC (BM) 2008-09-18 WO disclosed